ERBB2 and acute lymphoblastic leukemia: Five patients had CD20+HER2/neu+ ALL (4 with c-ALL, 1 with precursor B-ALL), four CD20+HER2/neu− ALL, and four CD20−HER2/neu− ALL (both 2 with c-ALL and precursor B-ALL each).